People on the Move
Calbiotech
Calbiotech, a contract manufacturer of immunoassay products for reference labs, has hired Dr Jimin Wang as VP of research and development to lead projects at a new GMP monoclonal antibody production facility.
Reema Boccia, Calbiotech spokeswoman, told Outsourcing-Pharma.com Wang had been hired because of his research experience in immunotherapy:
“Dr. Wang had managed the antibody and immunoassay groups at Invitrogen and developed hundred antibodies and immunoassays.
“He will set up and define the processes at Calbiotech to develop several novel monoclonal antibodies for immunoassays, and will expand our capacity as internal and external market needs increase.”
After obtaining an MD and PhD from Shanghai Second Medical University, Wang has worked for more than 15 years on antibody and assays development.
Most recently, he managed Hybridoma’s antibody proudction facility, and cytokine and signaling assay development in ELISAs and Luminex platforms at BioSource/Invitrogen.